Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy - Full Text View

Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy

This study has been completed.

Sponsored by:	University of Minnesota
Information provided by:	University of Minnesota
ClinicalTrials.gov Identifier:	NCT00177112

Purpose

The purpose of this study is to verify that the incidence rate of urinary tract infections after a routine outpatient cystoscopy is the same for non-sterile (clean) and sterile procedural techniques.

Condition	Intervention	Phase
Urinary Tract Infections	Procedure: clean patient preparation for cystoscopy Procedure: sterile patient preparation for cystoscopy	Phase III

MedlinePlus related topics:

Urinary Tract Infections

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Official Title:	Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy

Further study details as provided by University of Minnesota:

Primary Outcome Measures:

To verify that the incidence rate of urinary tract infections after a routine outpatient cystoscopy is the same for non-sterile (clean) and sterile procedural techniques

Estimated Enrollment:	275
Study Start Date:	June 2005
Study Completion Date:	October 2007

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

18 years of age or older
Patients undergoing routine outpatient flexible cystoscopy

Exclusion Criteria:

Patients who have had a urinary tract infection within 3 months prior to flexible cystoscopy
Patients with an indwelling catheter

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00177112

Locations


United States, Minnesota
	VAMC Minneapolis
	Minneapolis, Minnesota, United States, 55417

Sponsors and Collaborators

University of Minnesota

Investigators


Principal Investigator:	Kyle Anderson, MD	VAMC Minneapolis

More Information

Responsible Party:	University of Minnesota ( Manoj Monga, MD )
Study ID Numbers:	0412M65852, 3519A
First Received:	September 13, 2005
Last Updated:	January 31, 2008
ClinicalTrials.gov Identifier:	NCT00177112
Health Authority:	United States: Institutional Review Board

Keywords provided by University of Minnesota:

Cystoscopy

Study placed in the following topic categories:

Urologic Diseases

Urinary Tract Infections

Additional relevant MeSH terms:

Communicable Diseases

Infection

ClinicalTrials.gov processed this record on October 23, 2008